Reader Poll: Are You Treating More Diabetes Patients With Empagliflozin?Reader Poll: Are You Treating More Diabetes Patients With Empagliflozin?

In September 2015, researchers presented data at the European Association for the Study of Diabetes (EASD) meeting in Stockholm indicating that a diabetes drug for the first time offered cardiac benefits in addition to lowering blood glucose.

Source: Medscape Medical News Headlines - January 22, 2016 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news